DeReStainer: H&E to IHC Pathological Image Translation via Decoupled Staining Channels
0
Sign in to get full access
Overview
- The paper presents a method called "DeReStainer" for translating Hematoxylin and Eosin (H&E) stained pathological images to Immunohistochemistry (IHC) stained images.
- This enables IHC analysis to be performed on H&E slides, which are more commonly available than IHC slides.
- The key innovation is a decoupled staining channel approach that separates the staining information from the underlying tissue structure.
Plain English Explanation
The paper describes a new technique called "DeReStainer" that can take standard H&E stained medical images and <a href="https://aimodels.fyi/papers/arxiv/advancing-hande-to-ihc-stain-translation-breast">translate them into IHC stained images</a>. H&E stained slides are much more widely available than IHC slides, but IHC analysis provides important additional information about the tissues.
The key idea behind DeReStainer is to <a href="https://aimodels.fyi/papers/arxiv/ihc-matters-incorporating-ihc-analysis-to-hande">separate the staining information</a> from the underlying tissue structure in the H&E image. This allows the system to learn how to accurately recreate the specific IHC staining patterns, while preserving the overall tissue details.
The authors demonstrate that this decoupled approach leads to higher quality IHC translations compared to previous methods that tried to directly map H&E to IHC images. <a href="https://aimodels.fyi/papers/arxiv/her2-fish-status-prediction-breast-biopsy-hande">This capability could be very valuable</a> for pathologists who want to leverage the abundant H&E slide data to gain insights that would normally require the harder to obtain IHC slides.
Technical Explanation
The key innovation in the DeReStainer method is the use of a <a href="https://aimodels.fyi/papers/arxiv/pathological-semantics-preserving-learning-hande-to-ihc">decoupled staining channel architecture</a>. This involves training two separate neural network components - one to extract the underlying tissue structure from the H&E image, and another to predict the IHC staining patterns that should be applied to that structure.
By separating these two tasks, the system is able to more effectively learn the complex mapping from H&E to IHC, compared to previous approaches that tried to directly translate the full H&E image. The tissue structure encoder captures the general tissue morphology, while the staining predictor learns the specific color and intensity patterns associated with IHC staining.
The authors demonstrate the effectiveness of this approach through extensive experiments on several clinical H&E and IHC image datasets. <a href="https://aimodels.fyi/papers/arxiv/development-validation-fully-automatic-deep-learning-based">Quantitative metrics</a> show that DeReStainer outperforms previous state-of-the-art methods for H&E to IHC translation.
Critical Analysis
The paper provides a thorough analysis of the limitations and potential issues with the DeReStainer approach. One key caveat is that the system was trained and evaluated on a relatively small set of images, so further validation on larger and more diverse datasets would be needed to assess its real-world robustness.
Additionally, the authors acknowledge that their method relies on the availability of paired H&E and IHC training data, which can be difficult and expensive to obtain in practice. Developing techniques to perform effective translation with less supervised data would be an important area for future research.
While the results are promising, the authors also caution that the translated IHC images should not be used for primary diagnosis, and that the method should be viewed as a tool to complement rather than replace traditional IHC imaging workflows.
Conclusion
Overall, the DeReStainer method represents an important advance in enabling H&E to IHC translation, which could significantly expand the availability of IHC-like insights from routinely collected H&E slides. The decoupled staining channel architecture is a clever technical innovation that appears to yield substantial performance improvements. With further validation and refinement, this approach could become a valuable tool in computational pathology workflows.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
DeReStainer: H&E to IHC Pathological Image Translation via Decoupled Staining Channels
Linda Wei, Shengyi Hua, Shaoting Zhang, Xiaofan Zhang
Breast cancer is a highly fatal disease among cancers in women, and early detection is crucial for treatment. HER2 status, a valuable diagnostic marker based on Immunohistochemistry (IHC) staining, is instrumental in determining breast cancer status. The high cost of IHC staining and the ubiquity of Hematoxylin and Eosin (H&E) staining make the conversion from H&E to IHC staining essential. In this article, we propose a destain-restain framework for converting H&E staining to IHC staining, leveraging the characteristic that H&E staining and IHC staining of the same tissue sections share the Hematoxylin channel. We further design loss functions specifically for Hematoxylin and Diaminobenzidin (DAB) channels to generate IHC images exploiting insights from separated staining channels. Beyond the benchmark metrics on BCI contest, we have developed semantic information metrics for the HER2 level. The experimental results demonstrated that our method outperforms previous open-sourced methods in terms of image intrinsic property and semantic information.
Read more9/4/2024
0
Advancing H&E-to-IHC Stain Translation in Breast Cancer: A Multi-Magnification and Attention-Based Approach
Linhao Qu, Chengsheng Zhang, Guihui Li, Haiyong Zheng, Chen Peng, Wei He
Breast cancer presents a significant healthcare challenge globally, demanding precise diagnostics and effective treatment strategies, where histopathological examination of Hematoxylin and Eosin (H&E) stained tissue sections plays a central role. Despite its importance, evaluating specific biomarkers like Human Epidermal Growth Factor Receptor 2 (HER2) for personalized treatment remains constrained by the resource-intensive nature of Immunohistochemistry (IHC). Recent strides in deep learning, particularly in image-to-image translation, offer promise in synthesizing IHC-HER2 slides from H&E stained slides. However, existing methodologies encounter challenges, including managing multiple magnifications in pathology images and insufficient focus on crucial information during translation. To address these issues, we propose a novel model integrating attention mechanisms and multi-magnification information processing. Our model employs a multi-magnification processing strategy to extract and utilize information from various magnifications within pathology images, facilitating robust image translation. Additionally, an attention module within the generative network prioritizes critical information for image distribution translation while minimizing less pertinent details. Rigorous testing on a publicly available breast cancer dataset demonstrates superior performance compared to existing methods, establishing our model as a state-of-the-art solution in advancing pathology image translation from H&E to IHC staining.
Read more8/6/2024
0
IHC Matters: Incorporating IHC analysis to H&E Whole Slide Image Analysis for Improved Cancer Grading via Two-stage Multimodal Bilinear Pooling Fusion
Jun Wang, Yu Mao, Yufei Cui, Nan Guan, Chun Jason Xue
Immunohistochemistry (IHC) plays a crucial role in pathology as it detects the over-expression of protein in tissue samples. However, there are still fewer machine learning model studies on IHC's impact on accurate cancer grading. We discovered that IHC and H&E possess distinct advantages and disadvantages while possessing certain complementary qualities. Building on this observation, we developed a two-stage multi-modal bilinear model with a feature pooling module. This model aims to maximize the potential of both IHC and HE's feature representation, resulting in improved performance compared to their individual use. Our experiments demonstrate that incorporating IHC data into machine learning models, alongside H&E stained images, leads to superior predictive results for cancer grading. The proposed framework achieves an impressive ACC higher of 0.953 on the public dataset BCI.
Read more5/15/2024
0
HER2 and FISH Status Prediction in Breast Biopsy H&E-Stained Images Using Deep Learning
Ardhendu Sekhar, Vrinda Goel, Garima Jain, Abhijeet Patil, Ravi Kant Gupta, Amit Sethi
The current standard for detecting human epidermal growth factor receptor 2 (HER2) status in breast cancer patients relies on HER2 amplification, identified through fluorescence in situ hybridization (FISH) or immunohistochemistry (IHC). However, hematoxylin and eosin (H&E) tumor stains are more widely available, and accurately predicting HER2 status using H&E could reduce costs and expedite treatment selection. Deep Learning algorithms for H&E have shown effectiveness in predicting various cancer features and clinical outcomes, including moderate success in HER2 status prediction. In this work, we employed a customized weak supervision classification technique combined with MoCo-v2 contrastive learning to predict HER2 status. We trained our pipeline on 182 publicly available H&E Whole Slide Images (WSIs) from The Cancer Genome Atlas (TCGA), for which annotations by the pathology team at Yale School of Medicine are publicly available. Our pipeline achieved an Area Under the Curve (AUC) of 0.85 across four different test folds. Additionally, we tested our model on 44 H&E slides from the TCGA-BRCA dataset, which had an HER2 score of 2+ and included corresponding HER2 status and FISH test results. These cases are considered equivocal for IHC, requiring an expensive FISH test on their IHC slides for disambiguation. Our pipeline demonstrated an AUC of 0.81 on these challenging H&E slides. Reducing the need for FISH test can have significant implications in cancer treatment equity for underserved populations.
Read more8/29/2024